Topical photodynamic therapy (PDT) has been applied to almost all types of nonmelanoma skin cancer and numerous superficial benign skin disorders. Strategies to improve the accumulation of photosensitizer in the skin have been studied in recent years. Although the hydrophilic phthalocyanine zinc compound, zinc phthalocyanine tetrasulfonate (ZnPcSO4) has shown high photodynamic efficiency and reduced phototoxic side effects in the treatment of brain tumors and eye conditions, its use in topical skin treatment is currently limited by its poor skin penetration. In this study, nanodispersions of monoolein (MO)-based liquid crystalline phases were studied for their ability to increase ZnPcSO4 uptake by the skin. Lamellar, hexagonal and cubic crystalline phases were prepared and identified by polarizing light microscopy, and the nanodispersions were analyzed by dynamic light scattering. In vitro skin penetration studies were performed using a Franz's cell apparatus, and the skin uptake was evaluated in vivo in hairless mice. Aqueous dispersions of cubic and hexagonal phases showed particles of nanometer size, approximately 224 ±10 nm and 188 ± 10 nm, respectively. In vitro skin retention experiments revealed higher fluorescence from the ZnPcSO4 in deeper skin layers when this photosensitizer was loaded in the hexagonal nanodispersion system when compared to both the cubic phase nanoparticles and the bulk crystalline phases (lamellar, cubic and hexagonal). The hexagonal nanodispersion showed a similar penetration behavior in animal tests. These results are important findings, suggesting the development of MO liquid crystal nanodispersions as potential delivery systems to enhance the efficacy of topical PDT.Keywords: Liquid crystalline phases, nanodispersion, skin cancer, skin penetration, photodynamic therapy, zinc phthalocyanine.
INTRODUCTIONTopical photodynamic therapy (PDT) has been applied to almost every type of superficial nonmelanoma skin cancer and numerous benign skin disorders [1][2]. PDT is based on the administration of a photosensitizing drug and its selective retention in malignant tissue and its subsequent activation by light at specific wavelengths, causing cell death by the production of free radicals and/or reactive oxygen species [3,4]. Numerous strategies have been studied in recent years in attempts to improve the accumulation of photosensitizers and their precursors in the skin, including the use of microemulsions [5] [13][14][15]. Lipophilic phthalocyanines (e.g., zinc and chloroaluminum compounds) have been widely used as photosensitizers in preclinical studies of PDT for the treatment of skin cancer [16,17]. In contrast, the water-soluble zinc phthalocyanine tetrasulfonate (ZnPcSO 4 ) has displayed high photodynamic efficiency and reduced phototoxic side effects in the treatment of brain and ocular tumors [18]. However, with exception of a few studies [19][20][21], there is a lack of data on the application of ZnPcSO 4 in PDT for skin cancer.Their ability to control the release of dru...